<div align="center">

# üó∫Ô∏è Technical Roadmap

### Future Platform Evolution, Integrations & Infrastructure

**From Therapeutic AI to Comprehensive Care Orchestration Platform**

---

![Version](https://img.shields.io/badge/Roadmap-v6.0-blue?style=flat-square)
![Timeline](https://img.shields.io/badge/Timeline-Dec_2025--Dec_2027-orange?style=flat-square)
![Status](https://img.shields.io/badge/Status-Accelerated-brightgreen?style=flat-square)

</div>

---

## üéØ Vision: The Care Orchestration Platform

The Lilo Engine is evolving from a **therapeutic AI companion** to a **comprehensive care orchestration platform** that integrates:

- **AI-Powered Therapy** (Current) - Multi-agent therapeutic conversations
- **Remote Patient Monitoring** - Vital signs, activity tracking, health prediction
- **Smart Home Integration** - Ambient assisted living, environmental control
- **Healthcare Robotics** - Companion robots, telepresence, logistics
- **Edge-Cloud Architecture** - Low-latency local processing with cloud intelligence

```mermaid
flowchart TD
    subgraph Current["Current Platform (Built)"]
        C1["Multi-Agent AI<br/>7 therapeutic agents"]
        C2["Crisis Detection<br/>100% recall, <1s"]
        C3["Voice Pipeline<br/>Whisper + Piper"]
        C4["RAG System<br/>5 parallel streams"]
    end

    subgraph Phase1["Phase 1: Safety Infrastructure"]
        P1["Safety Kernel<br/>IEC 61508 compliant"]
        P2["Device Abstraction<br/>Multi-protocol support"]
        P3["Formal Verification<br/>Z3/TLA+ proofs"]
    end

    subgraph Phase2["Phase 2: Device Integration"]
        D1["RPM Devices<br/>Vitals, activity"]
        D2["Smart Home<br/>Alexa, Matter"]
        D3["Robotics<br/>ROS 2, ElliQ"]
    end

    subgraph Phase3["Phase 3: Edge-Cloud"]
        E1["Edge Nodes<br/>K3s, Jetson"]
        E2["Event Streaming<br/>Apache Pulsar"]
        E3["ML at Edge<br/><50ms inference"]
    end

    Current -->|"Enables"| Phase1
    Phase1 -->|"Unlocks"| Phase2
    Phase2 -->|"Requires"| Phase3

    style Current fill:#51cf66,color:#fff
    style P1 fill:#ff6b6b,color:#fff
```

---

## üìÖ Timeline Overview (Accelerated)

> **Major Update (Dec 2025):** Timeline compressed 40% based on discovery that 9 major components (3,000+ lines) are COMPLETE but not integrated. Engineering focus shifts from implementation to integration.

| Phase | Timeline | Investment | Priority | Key Deliverables |
|-------|----------|------------|----------|------------------|
| **Tactical** | Dec 2025 - Feb 2026 | $80-113K | ‚úÖ In Progress | Wire 9 complete implementations, edge prototype, pilot IRB |
| **Strategic Phase 1** | Apr - Jul 2026 | $200-280K | Critical | Pilot complete, edge production (3 facilities), FDA pre-sub |
| **Strategic Phase 2** | Aug - Dec 2026 | $300-400K | Critical | FDA De Novo submission, 10 facilities, prospective study |
| **Strategic Phase 3** | Jan - Dec 2027 | $500-700K | High | FDA clearance, 30 facilities, RCT launch, $1M ARR |
| **Post-2027** | 2028+ | TBD | Medium | RCT complete, Medicare, 100+ facilities, international |

**Total Investment**: $0.9M - $1.3M over 2 years (reduced from $2.0-2.5M due to velocity + complete implementations)

---

## üöÄ Tactical Phase: Integration Sprint (Dec 2025 - Feb 2026)

**Timeline**: 2.5-3 months | **Investment**: $80-113K | **Priority**: ‚úÖ IN PROGRESS

### Complete Implementations Discovered (Ready to Wire)

| Component | Lines | Current Status | Integration Target |
|-----------|-------|----------------|-------------------|
| **Coreference Resolver** | 455 | ‚úÖ Complete | context_builder.py |
| **Ensemble Classifier** | 538 | ‚úÖ Complete | safety_service.py |
| **Crisis Explainer (XAI)** | 498 | ‚úÖ Complete | Care Manager dashboard |
| **Streaming STT** | 664 | ‚úÖ Complete | Voice WebSocket endpoint |
| **Emotion Detector** | 667 | ‚úÖ Complete | AffectState in base.py |
| **Internal Reflection** | 25KB | ‚úÖ Complete | generation_client.py |
| **Holistic Evaluator** | 25KB | ‚úÖ Complete | Response pipeline |
| **Memory Consolidation** | 60KB | ‚úÖ Complete | Enable in production |
| **Situational Awareness** | 48KB | ‚úÖ Complete | Enable proactive triggers |

**Impact:** Engineering focus shifts from implementation to integration (2-3h per task)

### Tactical Phase Deliverables

| Week | Focus | Deliverable |
|------|-------|-------------|
| Days 1-2 | Integration | Wire all 9 complete implementations |
| Days 3-7 | Entity-Aware | Entity persistence, entity-aware retrieval, Turn 4 fix |
| Weeks 2-4 | Infrastructure | MCP integration, safety architecture, streaming generation |
| Weeks 5-10 | Edge & Validation | Edge prototype, transparent reasoning, compliance groundwork |

---

## üõ°Ô∏è Phase 1: Safety-First Infrastructure

**Timeline**: Weeks 2-4 (Tactical) + Strategic Phase 1 | **Investment**: Included in Tactical + Phase 1 | **Priority**: CRITICAL

### Why Safety First?

Device integration without proper safety architecture creates:
- Regulatory violations (FDA, ISO 13485)
- Patient safety risks
- Legal liability exposure
- Technical debt (10x cost to retrofit)

### 1.1 Safety-Critical Architecture

```mermaid
flowchart TD
    subgraph Kernel["Safety Kernel (IEC 61508)"]
        K1["Deterministic Processing<br/><10ms guaranteed"]
        K2["Formal Verification<br/>Z3 theorem prover"]
        K3["Triple Redundancy<br/>Voting system"]
        K4["Hardware E-Stop<br/>Physical override"]
    end

    subgraph Monitoring["Safety Monitoring"]
        M1["Watchdog Timers<br/>Failure detection"]
        M2["Safety Interlocks<br/>Command validation"]
        M3["Audit Logger<br/>ISO 13485 compliant"]
    end

    subgraph Guarantees["Safety Guarantees"]
        G1["Zero safety failures<br/>in 1M simulations"]
        G2["100% audit coverage"]
        G3["<10ms safety latency"]
    end

    Kernel -->|"Enforces"| Monitoring
    Monitoring -->|"Provides"| Guarantees

    style Kernel fill:#ff6b6b,color:#fff
    style G1 fill:#51cf66,color:#fff
```

**Key Components:**
- **Deterministic Safety Kernel** - Real-time guarantees for critical decisions
- **Formal Verification Engine** - Mathematical proofs using Z3/TLA+
- **Redundancy Manager** - Triple modular redundancy for voting
- **Emergency Stop System** - Hardware-level override capability
- **Safety Interlock Controller** - Prevents unsafe command execution

### 1.2 Device Abstraction Layer

```mermaid
flowchart TD
    subgraph Protocols["Supported Protocols"]
        PR1["MQTT<br/>IoT devices"]
        PR2["CoAP<br/>Constrained devices"]
        PR3["HL7 FHIR<br/>Medical devices"]
        PR4["ROS 2<br/>Robotics"]
        PR5["Matter<br/>Smart home"]
        PR6["WebRTC<br/>Telepresence"]
    end

    DAL["Device Abstraction Layer<br/>IEEE 11073 PHD Compliant"]

    subgraph Safety["Safety Requirements"]
        S1["Command Verification"]
        S2["State Validation"]
        S3["Fail-Safe Defaults"]
        S4["Heartbeat Monitoring"]
    end

    subgraph Capabilities["Device Capabilities"]
        C1["RPM Devices"]
        C2["Smart Home"]
        C3["Robotics"]
        C4["Telepresence"]
    end

    Protocols -->|"Unified through"| DAL
    DAL -->|"Enforces"| Safety
    DAL -->|"Enables"| Capabilities

    style DAL fill:#228be6,color:#fff
```

**Deliverables:**
- Protocol adapter framework for 6+ protocols
- Device capability registry
- Safety constraint system
- Device simulator for testing

### 1.3 Infrastructure Modernization

| Component | Current State | Target State | Timeline |
|-----------|--------------|--------------|----------|
| **Orchestration** | Docker Compose | Kubernetes | Month 3 |
| **Service Mesh** | None | Istio/Linkerd | Month 4 |
| **Go Modules** | Hierarchical | Workspace pattern | Month 2 |
| **Monitoring** | Basic | Prometheus/Grafana | Month 5 |

---

## üß† Phase 2: ML Intelligence Enhancement

**Timeline**: Months 4-9 | **Investment**: $205-310K | **Priority**: HIGH

### 2.1 ML-Powered Intent Classification

```mermaid
flowchart TD
    subgraph Current["Current State"]
        C1["BGE Semantic<br/>92-95% accuracy"]
        C2["214 Prototypes<br/>Curated + validated"]
        C3["Semantic<br/>Agent selection"]
    end

    subgraph Target["Target State"]
        T1["Fine-tuned BERT<br/>95%+ accuracy"]
        T2["Active Learning<br/>Auto-expansion"]
        T3["Contextual Bandits<br/>Adaptive selection"]
    end

    subgraph Infrastructure["ML Infrastructure"]
        I1["MLflow Registry<br/>Model versioning"]
        I2["A/B Testing<br/>Continuous optimization"]
        I3["Auto-retraining<br/>Weekly cycles"]
    end

    Current -->|"Evolves to"| Target
    Target -->|"Powered by"| Infrastructure

    style T1 fill:#51cf66,color:#fff
    style T2 fill:#51cf66,color:#fff
    style T3 fill:#51cf66,color:#fff
```

**Improvements:**
- Fine-tuned BERT model achieving 95%+ accuracy
- Active learning pipeline for continuous improvement
- Contextual bandits for adaptive agent selection
- Outcome tracking for therapeutic effectiveness

### 2.2 EHR Integration (Epic & Cerner)

```mermaid
flowchart TD
    subgraph FHIR["FHIR R4 Gateway"]
        F1["SMART on FHIR<br/>OAuth 2.0"]
        F2["Clinical Resources<br/>Observation, DiagnosticReport"]
        F3["Assessment Codes<br/>PHQ-9: 44261-6<br/>GAD-7: 70274-6"]
    end

    subgraph EHR["EHR Systems"]
        E1["Epic<br/>MyChart integration"]
        E2["Oracle Health<br/>(Cerner)"]
        E3["Aggregators<br/>Redox, Particle"]
    end

    subgraph Capabilities["Integration Capabilities"]
        C1["Read patient data"]
        C2["Write assessments"]
        C3["Clinical documentation"]
        C4["Care team alerts"]
    end

    FHIR -->|"Connects to"| EHR
    FHIR -->|"Enables"| Capabilities

    style F1 fill:#228be6,color:#fff
```

**Revenue Impact:** Required for enterprise sales ($200-300K contracts)

---

## ‚òÅÔ∏è Phase 3: Edge-Cloud Infrastructure

**Timeline**: Months 7-12 | **Investment**: $250K | **Priority**: CRITICAL

### 3.1 Edge-Cloud Architecture

```mermaid
flowchart TB
    subgraph Edge["Edge Layer (Per Facility)"]
        E1["K3s Kubernetes<br/>Lightweight orchestration"]
        E2["NVIDIA Jetson<br/>ML inference"]
        E3["Local Models<br/><10MB compressed"]
        E4["Offline Operation<br/>Crisis detection"]
    end

    subgraph Cloud["Cloud Layer (Central)"]
        C1["Main K8s Cluster<br/>Full orchestration"]
        C2["GPU Nodes<br/>Model training"]
        C3["Long-term Storage<br/>Analytics"]
        C4["Multi-facility<br/>Coordination"]
    end

    subgraph Sync["Synchronization"]
        S1["NATS JetStream<br/>Event streaming"]
        S2["Eventual Consistency<br/>Conflict resolution"]
        S3["Priority Queue<br/>Safety events first"]
    end

    Edge <-->|"Bi-directional sync"| Sync
    Sync <-->|"Cloud processing"| Cloud

    style E2 fill:#76b900,color:#fff
    style E4 fill:#ff6b6b,color:#fff
```

**Edge Node Specifications:**
| Component | Specification | Purpose |
|-----------|--------------|---------|
| **Compute** | NVIDIA Jetson Orin | ML inference |
| **Orchestration** | K3s | Lightweight Kubernetes |
| **Storage** | 256GB NVMe | Local data |
| **Connectivity** | 4G/5G backup | Redundant network |
| **Latency** | <50ms | Critical interventions |

### 3.2 Real-Time Event Processing

```mermaid
flowchart TD
    subgraph Sources["Event Sources"]
        S1["Vital Monitors"]
        S2["Motion Sensors"]
        S3["Voice Input"]
        S4["Smart Home"]
        S5["Robotics"]
    end

    subgraph Pulsar["Apache Pulsar"]
        P1["Critical Events<br/>10 partitions, 3x replication<br/>10ms SLA"]
        P2["Telemetry<br/>100 partitions, 2x replication<br/>100ms SLA"]
    end

    subgraph CEP["Complex Event Processing"]
        C1["Fall + No Movement"]
        C2["Cardiac Distress"]
        C3["Wandering Detection"]
        C4["Medication Non-compliance"]
    end

    subgraph Actions["Automated Actions"]
        A1["Alert Care Staff"]
        A2["Notify Family"]
        A3["Environmental Adjust"]
        A4["Robot Dispatch"]
    end

    Sources -->|"Stream to"| Pulsar
    Pulsar -->|"Pattern matching"| CEP
    CEP -->|"Trigger"| Actions

    style P1 fill:#ff6b6b,color:#fff
```

**Event Processing Capacity:**
- 10,000+ events/second
- <10ms latency for critical events
- 7-day retention for critical, 30-day for telemetry
- Real-time pattern detection

### 3.3 Compliance & Certification

| Standard | Purpose | Timeline |
|----------|---------|----------|
| **ISO 13485** | Quality Management System | Month 10 |
| **IEC 62304** | Software Lifecycle | Month 11 |
| **ISO 14971** | Risk Management | Month 10 |
| **FDA De Novo** | Regulatory Pathway | Month 12 |
| **SOC 2 Type II** | Security Audit | Month 18 |
| **HITRUST** | Healthcare Security | Month 20 |

---

## üì± Phase 4: Device Integration

**Timeline**: Months 13-18 | **Investment**: $515-630K | **Priority**: MEDIUM

### 4.1 Remote Patient Monitoring (RPM)

**Market Opportunity:** CMS 2026 rule reduces RPM requirements from 16 days to 2 days/month, expanding market by 75%

**Revenue:** $1,560/patient/year Medicare billing = **$1.56M ARR per 1,000 patients**

```mermaid
flowchart TD
    subgraph Devices["Supported RPM Devices"]
        D1["Blood Pressure<br/>Omron, Withings"]
        D2["Pulse Oximetry<br/>Masimo, Nonin"]
        D3["Weight Scales<br/>Withings, iHealth"]
        D4["Glucose Monitors<br/>Dexcom, Abbott"]
        D5["Activity Trackers<br/>Fitbit, Apple Watch"]
    end

    subgraph Integration["Integration Stages"]
        I1["Stage 1: Read-only<br/>2 months"]
        I2["Stage 2: Alerts only<br/>1 month"]
        I3["Stage 3: Supervised<br/>1 month"]
        I4["Stage 4: Limited auto<br/>1 month"]
        I5["Stage 5: Full auto<br/>Ongoing"]
    end

    subgraph Value["Value Delivered"]
        V1["Early deterioration detection"]
        V2["Medication adherence"]
        V3["Fall risk prediction"]
        V4["Medicare billing"]
    end

    Devices -->|"Progressive rollout"| Integration
    Integration -->|"Enables"| Value

    style I1 fill:#51cf66,color:#fff
```

**Safety-First Approach:**
1. **Read-only monitoring** - 2 months validation
2. **Alerts without intervention** - 1 month testing
3. **Supervised interventions** - Human approval required
4. **Limited autonomous** - Constrained actions
5. **Full autonomous** - After clinical validation

### 4.2 Smart Home Integration

**Market:** Ambient Assisted Living growing from $9.5B (2025) to $50B (2032) at 27.1% CAGR

```mermaid
flowchart TD
    subgraph Platforms["Smart Home Platforms"]
        P1["Alexa Smart Properties<br/>75% of senior facilities"]
        P2["Matter Protocol<br/>Universal compatibility"]
        P3["Google Home<br/>Alternative option"]
    end

    subgraph Capabilities["Intervention Capabilities"]
        C1["Lighting Control<br/>Circadian rhythm"]
        C2["Temperature<br/>Comfort optimization"]
        C3["Music/Ambient<br/>Mood therapy"]
        C4["Reminders<br/>Medication, meals"]
        C5["Family Calls<br/>Video connection"]
    end

    subgraph Outcomes["Clinical Outcomes"]
        O1["34% reduction<br/>Agitation incidents"]
        O2["22% improvement<br/>Sleep quality"]
        O3["Reduced isolation<br/>Family connection"]
    end

    Platforms -->|"Enable"| Capabilities
    Capabilities -->|"Deliver"| Outcomes

    style O1 fill:#51cf66,color:#fff
    style O2 fill:#51cf66,color:#fff
```

**Initial Scope (Safety-Limited):**
- ‚úÖ Lighting adjustments
- ‚úÖ Temperature control
- ‚úÖ Music/ambient sound
- ‚ùå Door locks (deferred)
- ‚ùå Appliance control (deferred)

### 4.3 Clinical Validation Studies

| Parameter | Value |
|-----------|-------|
| **Facilities** | 3 assisted living |
| **Residents** | 100 total |
| **Duration** | 6 months |
| **Monitoring** | 24/7 safety engineer |
| **Outcome** | FDA submission data |

---

## ü§ñ Phase 5: Robotics & Advanced Features

**Timeline**: Months 19-24 | **Investment**: $200-300K | **Priority**: LOW

### 5.1 Healthcare Robotics

**Market:** 17.6% CAGR for companion robots, ROS 1 support ending 2025

```mermaid
flowchart TD
    subgraph ROS["ROS 2 Integration"]
        R1["ROS 2 Middleware<br/>Deterministic control"]
        R2["Safety Certification<br/>ISO 13849"]
        R3["Universal Bridge<br/>Multi-vendor support"]
    end

    subgraph Robots["Robot Types"]
        B1["ElliQ<br/>Companion (10K+ deployed)"]
        B2["Telepresence<br/>Family connection"]
        B3["Logistics<br/>Delivery, supplies"]
        B4["Rehabilitation<br/>Physical therapy assist"]
    end

    subgraph Revenue["Revenue Streams"]
        V1["$5-15K/facility/year<br/>Fleet management"]
        V2["$50-200K/integration<br/>OEM partnerships"]
    end

    ROS -->|"Enables"| Robots
    Robots -->|"Generates"| Revenue

    style R1 fill:#228be6,color:#fff
```

**Integration Priority:**
1. **ElliQ** - 10,000+ units already deployed
2. **Telepresence** - 58% adoption increase post-2024
3. **Logistics** - 15% of facilities have delivery robots

### 5.2 Mobile Applications

**Deferred from Phase 2 to focus on safety-critical infrastructure**

| App | Purpose | Platform |
|-----|---------|----------|
| **Resident App** | Self-service therapy | iOS/Android |
| **Family App** | Status monitoring | iOS/Android |
| **Staff App** | Alert management | iOS/Android/Web |

### 5.3 Advanced Analytics

- Predictive health deterioration
- Population health trends
- Therapeutic effectiveness research
- Anonymized research datasets

---

## üîß Technology Stack Evolution

### Current Stack (Production)

| Layer | Technology | Status |
|-------|------------|--------|
| **LLM** | Qwen 2.5-7B + llama.cpp | ‚úÖ Production |
| **Embeddings** | BGE-base-en-v1.5 | ‚úÖ Production |
| **Vector DB** | PostgreSQL + pgvector | ‚úÖ Production |
| **Cache** | Redis | ‚úÖ Production |
| **Orchestration** | Docker Compose | ‚úÖ Production |
| **Backend** | Go + Python | ‚úÖ Production |

### Target Stack (2026-2028)

| Layer | Technology | Timeline |
|-------|------------|----------|
| **Orchestration** | Kubernetes + K3s (edge) | Month 6 |
| **Service Mesh** | Istio | Month 8 |
| **Event Streaming** | Apache Pulsar | Month 10 |
| **ML Platform** | MLflow + Kubeflow | Month 12 |
| **Edge Compute** | NVIDIA Jetson | Month 9 |
| **IoT Protocol** | MQTT + Matter | Month 14 |
| **Robotics** | ROS 2 | Month 20 |

---

## üí∞ Investment & ROI Summary

### Total Investment by Phase (Recalibrated Dec 2025)

```mermaid
pie title Investment Allocation ($0.9-1.3M over 2 years)
    "Tactical (Dec-Feb)" : 113
    "Strategic Phase 1 (Apr-Jul)" : 280
    "Strategic Phase 2 (Aug-Dec)" : 400
    "Strategic Phase 3 (2027)" : 650
```

> **Note:** Investment reduced by ~$800K from original estimates due to:
> - 9 major components discovered complete (3,000+ lines)
> - 40% velocity acceleration based on demonstrated development speed

### ROI Justification

**Cost of NOT Building Safety-First:**
- Patient injury lawsuit: $5-50M
- FDA shutdown: $10M+ lost revenue
- Retrofit cost: 10x = $7M+

**Benefits of Safety-First:**
- FDA Fast Track eligibility: 6 months faster
- Insurance savings: $200K/year
- Enterprise confidence: 2x close rate
- Premium pricing: +20% per contract

### Revenue Projections (2025-2028)

| Milestone | Date | Facilities | Residents | ARR |
|-----------|------|------------|-----------|-----|
| Pilot Complete | Feb 2026 | 1 | 50 | $0 |
| Phase 1 End | Jul 2026 | 3 | 200 | $30K |
| Phase 2 End | Dec 2026 | 10 | 700 | $200K |
| Phase 3 End | Dec 2027 | 30 | 2,000 | $1M |
| Post-2027 | 2028 | 100+ | 7,000+ | $5M+ |
| Vision | 2029 | 200+ | 15,000+ | $10M+ |

### Unit Economics (Target Dec 2027)

| Metric | Value |
|--------|-------|
| Price per Resident/Month | $50-75 |
| Gross Margin | 65-75% |
| CAC | $500-1,000 |
| LTV | $2,500-4,000 |
| LTV:CAC | 4-5x |

---

## üéØ Critical Milestones (Accelerated 2-Year Timeline)

| Date | Milestone | Gate Criteria | Risk if Skipped |
|------|-----------|---------------|-----------------|
| **Feb 2026** | Tactical Complete | 9 components wired, edge prototype | ‚ö†Ô∏è HIGH |
| **Apr 2026** | Pilot Study Complete | n=20 results positive | ‚ùå SEVERE |
| **May 2026** | Edge Production | 3 facilities deployed | ‚ö†Ô∏è HIGH |
| **Jun 2026** | FDA Pre-Submission | Clear pathway feedback | ‚ùå SEVERE |
| **Jul 2026** | First Enterprise Contracts | 3 contracts signed | ‚ö†Ô∏è MEDIUM |
| **Oct 2026** | FDA De Novo Submitted | Complete package accepted | ‚ùå CRITICAL |
| **Dec 2026** | 10 Facility Deployment | Enterprise scaling | ‚ö†Ô∏è MEDIUM |
| **Jun 2027** | FDA Clearance | De Novo granted | ‚ùå CRITICAL |
| **Dec 2027** | Scale Target | 30 facilities, $1M ARR | ‚ö†Ô∏è MEDIUM |

---

## üèÅ Strategic Window

**The 2-Year Accelerated Opportunity (Dec 2025 - Dec 2027):**

1. **Complete Implementations** - 9 major components ready to wire (3,000+ lines)
2. **Demonstrated Velocity** - 65K lines built in 4 months by solo developer
3. **Demographic Urgency** - Baby Boomers hitting 80+ (highest care need)
4. **Regulatory Tailwind** - CMS RPM expansion (2 days/month vs 16), FHIR mandates
5. **Technology Maturity** - Edge AI, Matter protocol, ROS 2 production-ready
6. **Competitive Gap** - No integrated competitor combines AI + RPM + Smart Home + Robotics

**Vision by Dec 2027:** FDA-cleared AI companion serving 2,000+ residents across 30 facilities with $1M ARR.

**Post-2027:** 100+ facilities, Medicare reimbursement, international expansion (UK/EU).

---

<div align="center">

**¬© 2025 Aejaz Sheriff / PragmaticLogic AI**

[Back to README](../README.md) ‚Ä¢ [Process Flow](./PROCESS_FLOW.md) ‚Ä¢ [Technical Portfolio](./TECHNICAL_PORTFOLIO.md) ‚Ä¢ [Investor Overview](./INVESTOR_OVERVIEW.md)

</div>
